Xiuxin Han

760 total citations
28 papers, 517 citations indexed

About

Xiuxin Han is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Xiuxin Han has authored 28 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Xiuxin Han's work include Cancer Diagnosis and Treatment (5 papers), Sarcoma Diagnosis and Treatment (5 papers) and Cancer-related molecular mechanisms research (5 papers). Xiuxin Han is often cited by papers focused on Cancer Diagnosis and Treatment (5 papers), Sarcoma Diagnosis and Treatment (5 papers) and Cancer-related molecular mechanisms research (5 papers). Xiuxin Han collaborates with scholars based in China, United States and Russia. Xiuxin Han's co-authors include Guowen Wang, Guowen Wang, Chao Zhang, Xu Guo, Xin Wang, Yulin Ma, Yao Xu, Lili Li, Владимир П. Баклаушев and Shunbin Xiong and has published in prestigious journals such as PLoS ONE, International Journal of Cancer and Frontiers in Immunology.

In The Last Decade

Xiuxin Han

26 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiuxin Han China 16 211 207 169 138 123 28 517
Yunxian Mo China 14 205 1.0× 168 0.8× 141 0.8× 162 1.2× 102 0.8× 32 562
Maria D. Begnami Brazil 11 280 1.3× 218 1.1× 179 1.1× 157 1.1× 73 0.6× 22 560
Choichiro Ozu Japan 12 269 1.3× 146 0.7× 158 0.9× 247 1.8× 114 0.9× 22 579
Wendong Gu China 18 243 1.2× 255 1.2× 283 1.7× 192 1.4× 272 2.2× 56 784
Willa Shi Canada 7 238 1.1× 113 0.5× 200 1.2× 138 1.0× 150 1.2× 7 563
Jiaolin Zhou China 13 265 1.3× 144 0.7× 59 0.3× 195 1.4× 122 1.0× 57 528
Junzhou Wu China 15 321 1.5× 176 0.9× 201 1.2× 167 1.2× 133 1.1× 30 645
Ji Zhou China 16 292 1.4× 174 0.8× 129 0.8× 43 0.3× 91 0.7× 39 621
Pei Dong China 16 157 0.7× 276 1.3× 313 1.9× 214 1.6× 176 1.4× 60 666

Countries citing papers authored by Xiuxin Han

Since Specialization
Citations

This map shows the geographic impact of Xiuxin Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiuxin Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiuxin Han more than expected).

Fields of papers citing papers by Xiuxin Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiuxin Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiuxin Han. The network helps show where Xiuxin Han may publish in the future.

Co-authorship network of co-authors of Xiuxin Han

This figure shows the co-authorship network connecting the top 25 collaborators of Xiuxin Han. A scholar is included among the top collaborators of Xiuxin Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiuxin Han. Xiuxin Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Xiuxin, Yiqin Li, Yongheng Liu, et al.. (2025). Integrated multi-omics reveals GABARAP-mediated mitophagy and pyruvate metabolism as key drivers of osteosarcoma progression. Frontiers in Immunology. 16. 1680554–1680554.
2.
Chen, Long, Jianchao Liu, Xiuxin Han, et al.. (2025). Integrated single-cell and bulk transcriptome analysis of R-loop score-based signature with regard to immune microenvironment, lipid metabolism and prognosis in HCC. Frontiers in Immunology. 15. 1487372–1487372. 2 indexed citations
3.
Zhang, Yan, et al.. (2024). CD93 aggravates cell proliferation, angiogenesis and immune escape in osteosarcoma through triggering the PI3K/AKT pathway. Journal of Orthopaedic Science. 30(4). 685–691. 1 indexed citations
4.
Feng, Jinyan, Long Chen, Chao Zhang, et al.. (2024). METTL3-mediated m6A modification of LINC00520 confers glycolysis and chemoresistance in osteosarcoma via suppressing ubiquitination of ENO1. Cancer Letters. 611. 217194–217194. 13 indexed citations
5.
Feng, Jinyan, Yongheng Liu, Yanting Zhang, et al.. (2023). Identification of topoisomerase 2A as a novel bone metastasis-related gene in liver hepatocellular carcinoma. Aging. 15(22). 13010–13040. 3 indexed citations
6.
Feng, Jinyan, Jinwu Wang, Yao Xu, et al.. (2023). Construction and validation of a novel cuproptosis-mitochondrion prognostic model related with tumor immunity in osteosarcoma. PLoS ONE. 18(7). e0288180–e0288180. 7 indexed citations
7.
Zhang, Yanting, et al.. (2023). Twenty‐year outcome of prevalence, incidence, mortality and survival rate in patients with malignant bone tumors. International Journal of Cancer. 154(2). 226–240. 29 indexed citations
8.
Zhang, Chao, Xu Guo, Yao Xu, et al.. (2019). Lung metastases at the initial diagnosis of high-grade osteosarcoma: prevalence, risk factors and prognostic factors. A large population-based cohort study. Sao Paulo Medical Journal. 137(5). 423–429. 32 indexed citations
9.
Guo, Xu, Yao Xu, Xin Wang, et al.. (2019). Advanced Hepatocellular Carcinoma with Bone Metastases: Prevalence, Associated Factors, and Survival Estimation. Medical Science Monitor. 25. 1105–1112. 21 indexed citations
11.
Guo, Xu, Chao Zhang, Wenjuan Ma, et al.. (2019). Patterns of bone metastases in newly diagnosed colorectal cancer: a real-world analysis in the SEER database. International Journal of Colorectal Disease. 34(3). 533–543. 20 indexed citations
12.
Guo, Qi, Chao Zhang, Xu Guo, et al.. (2018). Incidence of bone metastasis and factors contributing to its development and prognosis in newly diagnosed renal cell carcinoma: a population-based study. Cancer Management and Research. Volume 10. 2935–2944. 26 indexed citations
13.
Guo, Xu, Chao Zhang, Qi Guo, et al.. (2018). The homogeneous and heterogeneous risk factors for the morbidity and prognosis of bone metastasis in patients with prostate cancer. Cancer Management and Research. Volume 10. 1639–1646. 38 indexed citations
14.
Zhang, Chao, Lele Liu, Xu Guo, et al.. (2018). Bone Metastases Pattern in Newly Diagnosed Metastatic Bladder Cancer: A Population-Based Study. Journal of Cancer. 9(24). 4706–4711. 26 indexed citations
15.
Li, Lin, Amanda R. Wasylishen, Yanqin Zhang, et al.. (2016). PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway. Oncotarget. 7(14). 18021–18035. 22 indexed citations
16.
Ren, Zhiwu, Jilong Yang, Xiuxin Han, et al.. (2015). Coexpression of CXCR4 and MMP9 predicts lung metastasis and poor prognosis in resected osteosarcoma. Tumor Biology. 37(4). 5089–5096. 39 indexed citations
17.
Ren, Zhiwu, Xiuxin Han, Jilong Yang, et al.. (2015). PLA2G16 Expression in Human Osteosarcoma Is Associated with Pulmonary Metastasis and Poor Prognosis. PLoS ONE. 10(5). e0127236–e0127236. 21 indexed citations
18.
Ma, Yulin, et al.. (2013). Metformin Synergistically Enhances Antitumor Activity of Histone Deacetylase Inhibitor Trichostatin A Against Osteosarcoma Cell Line. DNA and Cell Biology. 32(4). 156–164. 27 indexed citations
19.
Han, Xiuxin, et al.. (2013). Comparison of FDG PET/CT and Gadolinium-Enhanced MRI for the Detection of Bone Metastases in Patients With Cancer. Clinical Nuclear Medicine. 38(5). 343–348. 16 indexed citations
20.
Wang, Guowen, et al.. (2012). APE1 gene silencing promotes the sensitivity of osteosarcoma U2-OS cells to bortezomib. Clinical Oncology and Cancer Research. 39(8). 429–432. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026